What is Cosmos Health Inc.'s earnings per share (EPS)?

Cosmos Health Inc. (COSM) reported diluted earnings per share of -$0.63 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cosmos Health Inc. Financials

COSM

Trailing 12 months to June 30, 2026

Revenue $73.7M +33.8% YoY

Net Income -$24.4M -58.7% YoY

EPS (Diluted) -$0.63 FY2025 annual

Free Cash Flow -$9.9M -105.8% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 18, 2026 Currency USD FYE December

Cosmos Health Inc. (COSM) reported $73.7M in revenue over the twelve months to Jun 30, 2026, up 33.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI COSM FY2025 2026-08-30

Revenue growth is being absorbed by overhead, leaving a financing-dependent model despite a partial recovery in gross margin.

Gross margin recovered to 12.1% in FY2025, reversing the prior year's trough. That improvement did not reach operating earnings: SG&A reached $15.6M while operating margin remained -25.6%, showing that overhead, rather than product costs alone, is constraining profitability.

Revenue reached $65.3M in FY2025, but gross profit was only $7.9M; the business therefore has a thin contribution cushion before overhead, interest, and other costs. A current ratio of 1.0x alongside reported liquidity of 1.1 months indicates limited short-term balance-sheet flexibility.

Operating cash flow was -$8.4M and free cash flow was -$8.5M, nearly identical; accounting losses are translating into cash losses rather than being mainly explained by reinvestment. With capital spending of just $56K, financing cash inflow of $14.1M was the principal offset to ongoing operations.

Financial Health Signals

Financial Health Score 26/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cosmos Health Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Distress

-2.40

Cosmos Health Inc. scores -2.40, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($22.6M) relative to total liabilities ($47.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Cosmos Health Inc. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Cosmos Health Inc. reported a net loss of $19.1M while operations used $8.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Cosmos Health Inc. reported an operating loss of $16.7M against $1.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$65.3M

YoY+19.9%

5Y CAGR+3.3%

10Y CAGR+61.7%

Cosmos Health Inc. generated $65.3M in revenue in fiscal year 2025. This represents an increase of 19.9% from the prior year.

EBITDA

-$15.3M

YoY-7.1%

Cosmos Health Inc.'s EBITDA was -$15.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.1% from the prior year.

Net Income

-$19.1M

YoY-18.3%

Cosmos Health Inc. reported -$19.1M in net income in fiscal year 2025. This represents a decrease of 18.3% from the prior year.

EPS (Diluted)

-$0.63

Cosmos Health Inc. earned -$0.63 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$8.5M

YoY-4.5%

Cosmos Health Inc. recorded an outflow of $8.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 4.5% from the prior year.

Cash & Debt

$716K

YoY+127.1%

5Y CAGR+2.6%

10Y CAGR+13.7%

Cosmos Health Inc. held $716K in cash against $3.8M in long-term debt as of fiscal year 2025, with $38.3M of liabilities due within a year.

Shares Outstanding

51M

Cosmos Health Inc. had 51M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

12.1%

YoY+4.2pp

5Y CAGR-2.4pp

10Y CAGR+2.9pp

Cosmos Health Inc.'s gross margin was 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.2 percentage points from the prior year.

Operating Margin

-25.6%

YoY+3.0pp

5Y CAGR-30.5pp

10Y CAGR+57.3pp

Cosmos Health Inc.'s operating margin was -25.6% in fiscal year 2025, reflecting core business profitability. This is up 3.0 percentage points from the prior year.

Net Margin

-29.3%

YoY+0.4pp

5Y CAGR-30.8pp

Cosmos Health Inc.'s net profit margin was -29.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.4 percentage points from the prior year.

Return on Equity

-103.9%

YoY-37.9pp

Cosmos Health Inc.'s ROE was -103.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 37.9 percentage points from the prior year.

Capital Allocation

R&D Spending

$519K

YoY-2.6%

Cosmos Health Inc. invested $519K in research and development in fiscal year 2025. This represents a decrease of 2.6% from the prior year.

Capital Expenditures

$56K

YoY-86.7%

5Y CAGR-13.9%

Cosmos Health Inc. invested $56K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 86.7% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

COSM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

COSM quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$73.7M	$65.3M+19.9%	$54.4M+2.0%	$53.4M+6.0%	$50.3M-10.5%	$56.2M+1.5%	$55.4M+39.6%	$39.7M+7.0%	$37.1M+23.6%	$30.0M+344.3%	$6.8M+1165.5%	$534K-93.0%	$7.6M+746.6%	$902K	N/A	N/A
Cost of Revenue	$66.2M	$57.4M+14.5%	$50.1M+2.2%	$49.0M+10.4%	$44.4M-7.3%	$47.9M+1.2%	$47.3M+31.5%	$36.0M+3.9%	$34.7M+23.6%	$28.1M+355.9%	$6.2M+1169.4%	$485K	N/A	N/A	N/A	N/A
Gross Profit	$7.6M	$7.9M+83.1%	$4.3M-0.9%	$4.3M-27.0%	$6.0M-28.5%	$8.3M+3.4%	$8.1M+120.1%	$3.7M+52.0%	$2.4M+23.1%	$2.0M+225.5%	$601K+1126.8%	$49K-99.4%	$7.6M	N/A	N/A	N/A
R&D Expenses	$498K	$519K-2.6%	$533K+223.5%	$165K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$16.5M	$15.6M+33.1%	$11.7M-40.3%	$19.6M+92.9%	$10.2M+10.6%	$9.2M+337.9%	$2.1M-36.1%	$3.3M-8.5%	$3.6M-26.0%	$4.9M+511.1%	$794K+63.4%	$486K+9.7%	$443K+688.7%	$56K+12243.5%	$455	N/A
Operating Income	-$18.3M	-$16.7M-7.5%	-$15.5M+28.8%	-$21.8M-192.1%	-$7.5M-64.9%	-$4.5M-267.0%	$2.7M+1161.1%	-$256K+79.2%	-$1.2M+74.8%	-$4.9M-2306.0%	-$203K+54.2%	-$442K-106.2%	$7.1M+2364.7%	$289K+63553.2%	-$455	N/A
Interest Expense	$2.3M	$1.9M+87.7%	$1.0M+16.8%	$866K-63.1%	$2.3M-16.9%	$2.8M+2.3%	$2.8M+295.5%	-$1.4M-45.9%	-$968K-229.3%	$748K+294.6%	$190K+118.3%	$87K+36.8%	$64K	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0+100.0%	-$775K-779.8%	$114K+130.2%	-$378K-306.5%	$183K+1155.1%	-$17K-718.6%	$3K+264.2%	$769+278.8%	$203-100.0%	$997K+2413.0%	$40K	N/A	N/A
Net Income	-$24.4M	-$19.1M-18.3%	-$16.2M+12.7%	-$18.5M-34.1%	-$13.8M-73.7%	-$8.0M-1070.0%	$821K+124.9%	-$3.3M+63.6%	-$9.1M-45.9%	-$6.2M-933.2%	-$601K	N/A	$6.0M+2351.3%	$247K+54296.0%	-$455	N/A
EPS (Diluted)	—	-$0.63	-$1.17	-$2.15	-$33.16-39.7%	-$23.74	$0.06+124.0%	-$0.25+63.2%	-$0.68-38.8%	-$0.49-100.0%	$80741.00+161482100.0%	-$0.05-200.0%	$0.05	$0.00	$0.00	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$19.0M+5.9%	$17.9M-9.0%	$19.7M+15.2%	$17.1M+16.0%	$14.7M+7.5%	$13.7M-3.6%	$14.2M+14.6%	$12.4M
Cost of Revenue	$17.5M+5.6%	$16.5M-6.1%	$17.6M+21.5%	$14.5M+6.8%	$13.6M+16.5%	$11.7M-11.8%	$13.2M+18.0%	$11.2M
Gross Profit	$1.5M+9.4%	$1.4M-33.6%	$2.1M-20.1%	$2.6M+123.6%	$1.2M-43.2%	$2.0M+104.2%	$1.0M-16.8%	$1.2M
R&D Expenses	$69K	$0-100.0%	$411K+2140.1%	$18K-75.4%	$75K+377.6%	$16K-97.1%	$533K	$0
SG&A Expenses	$2.1M+14.8%	$1.8M-83.0%	$10.6M+420.0%	$2.0M+36.9%	$1.5M+0.8%	$1.5M-79.3%	$7.1M+300.5%	$1.8M
Operating Income	-$2.9M-33.9%	-$2.2M+80.9%	-$11.4M-527.2%	-$1.8M+31.2%	-$2.6M-217.5%	-$833K+90.7%	-$9.0M-300.3%	-$2.2M
Interest Expense	$602K+42.3%	$423K-35.4%	$655K-2.1%	$669K+72.1%	$389K+107.8%	$187K-41.5%	$320K+76.2%	$181K
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$6.1M-117.0%	-$2.8M+72.3%	-$10.1M-89.5%	-$5.4M-89.3%	-$2.8M-245.7%	-$818K+75.6%	-$3.3M+60.0%	-$8.4M
EPS (Diluted)	-$0.10	-$0.06+80.6%	-$0.31-82.4%	-$0.17-70.0%	-$0.10-233.3%	-$0.03	-$0.45	-$0.45

COSM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

COSM quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$65.5M+20.6%	$54.3M-17.7%	$66.0M-3.0%	$68.0M+37.6%	$49.4M+12.7%	$43.8M+83.6%	$23.9M+15.4%	$20.7M+93.9%	$10.7M+242.3%	$3.1M+374.2%	$658K-90.9%	$7.2M+734.4%	$867K	$0-100.0%	$15K
Current Assets	$38.4M+50.8%	$25.5M-30.4%	$36.6M-35.1%	$56.4M+41.5%	$39.8M-2.3%	$40.8M+92.5%	$21.2M+15.4%	$18.3M+92.9%	$9.5M+260.7%	$2.6M+381.9%	$547K-92.4%	$7.2M+733.9%	$865K	N/A	$15K
Cash & Equivalents	$716K+127.1%	$315K-91.8%	$3.8M-81.5%	$20.7M+7142.8%	$286K-54.4%	$628K+1530.6%	$39K-95.5%	$864K+10.4%	$783K+9.2%	$717K+261.8%	$198K-55.7%	$447K-48.3%	$864K	$0-100.0%	$15K
Inventory	$5.8M+32.7%	$4.4M-9.1%	$4.8M+38.7%	$3.5M+9.7%	$3.1M-4.4%	$3.3M-5.2%	$3.5M+8.5%	$3.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$19.6M+45.6%	$13.5M-31.8%	$19.8M-16.6%	$23.7M-10.6%	$26.5M+13.0%	$23.4M+219.0%	$7.3M+54.6%	$4.8M+278.6%	$1.3M+89.7%	$662K+585.5%	$97K	N/A	N/A	N/A	N/A
Goodwill	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K-97.5%	$1.9M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$47.1M+58.0%	$29.8M-0.6%	$30.0M+5.6%	$28.4M-37.0%	$45.0M-6.2%	$48.0M+58.2%	$30.3M+26.4%	$24.0M+75.2%	$13.7M+181.3%	$4.9M+155.7%	$1.9M+8.2%	$1.8M+91.3%	$921K+65526.1%	$1K-93.0%	$20K
Current Liabilities	$38.3M+48.6%	$25.8M+5.9%	$24.3M+11.8%	$21.7M-27.3%	$29.9M-12.7%	$34.3M+21.4%	$28.2M+26.8%	$22.3M+62.5%	$13.7M+181.3%	$4.9M+155.7%	$1.9M+8.2%	$1.8M	N/A	N/A	N/A
Long-Term Debt	$3.8M-8.1%	$4.1M+209.5%	$1.3M-73.5%	$5.0M+950.6%	$478K-95.6%	$10.8M	$0-100.0%	$146K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$18.4M-24.9%	$24.5M-31.9%	$36.0M-8.3%	$39.3M+797.0%	$4.4M+205.2%	-$4.2M+35.6%	-$6.5M-94.8%	-$3.3M-9.6%	-$3.0M-72.7%	-$1.8M-40.5%	-$1.2M-122.8%	$5.5M+10296.0%	-$54K-3726.4%	-$1K+70.5%	-$5K
Retained Earnings	-$133.2M-16.8%	-$114.0M-24.4%	-$91.6M-38.4%	-$66.2M-92.8%	-$34.3M-83.2%	-$18.8M+4.2%	-$19.6M-20.3%	-$16.3M-125.6%	-$7.2M-619.6%	-$1.0M-149.8%	-$401K-106.4%	$6.3M+2497.8%	$242K+5374.7%	-$5K	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$61.5M-1.5%	$62.4M-4.7%	$65.5M-5.8%	$69.5M+12.4%	$61.8M+8.1%	$57.2M+5.3%	$54.3M-15.8%	$64.5M
Current Assets	$36.7M-0.6%	$36.9M-3.9%	$38.4M+0.7%	$38.1M+24.7%	$30.6M+9.8%	$27.8M+9.4%	$25.5M-29.7%	$36.2M
Cash & Equivalents	$1.8M+249.9%	$515K-28.1%	$716K-19.5%	$889K+35.7%	$656K-11.8%	$743K+135.8%	$315K-90.5%	$3.3M
Inventory	$4.5M-20.0%	$5.7M-2.2%	$5.8M+1.7%	$5.7M+11.2%	$5.1M+7.9%	$4.7M+8.7%	$4.4M-10.8%	$4.9M
Accounts Receivable	$18.9M+3.7%	$18.2M-7.3%	$19.6M+8.9%	$18.0M+16.7%	$15.5M+8.4%	$14.3M+5.7%	$13.5M-22.9%	$17.5M
Goodwill	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K0.0%	$50K
Total Liabilities	$40.8M-4.1%	$42.5M-9.6%	$47.1M+1.5%	$46.4M+30.2%	$35.6M+14.0%	$31.2M+4.9%	$29.8M+0.8%	$29.5M
Current Liabilities	$34.8M+2.2%	$34.1M-11.0%	$38.3M-0.7%	$38.5M+23.6%	$31.2M+17.2%	$26.6M+3.2%	$25.8M+2.2%	$25.2M
Long-Term Debt	$3.2M-7.4%	$3.5M-8.6%	$3.8M-29.6%	$5.4M+3.4%	$5.2M+7.0%	$4.9M+18.1%	$4.1M-3.7%	$4.3M
Total Equity	$20.7M+4.3%	$19.8M+7.6%	$18.4M-20.4%	$23.1M-11.8%	$26.2M+1.1%	$26.0M+5.8%	$24.5M-29.9%	$35.0M
Retained Earnings	-$142.1M-4.5%	-$136.0M-2.1%	-$133.2M-8.2%	-$123.0M-4.5%	-$117.7M-2.5%	-$114.8M-0.7%	-$114.0M-9.1%	-$104.5M

COSM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

COSM quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$9.8M	-$8.4M-9.5%	-$7.7M+50.6%	-$15.6M-5.1%	-$14.9M-109.5%	-$7.1M+38.3%	-$11.5M-140.2%	-$4.8M-207.9%	-$1.6M+82.2%	-$8.8M-312.0%	-$2.1M-327.7%	-$497K-107.6%	$6.5M+684.9%	$831K+2681835.5%	$31	N/A
Capital Expenditures	$96K	$56K-86.7%	$418K-68.2%	$1.3M+1669.6%	$74K-87.2%	$581K+393.8%	$118K	N/A	$503K+809.6%	$55K+331.8%	$13K-70.8%	$44K+104.7%	$21K	N/A	N/A	N/A
Free Cash Flow	-$9.9M	-$8.5M-4.5%	-$8.1M+52.0%	-$16.9M-13.4%	-$14.9M-94.6%	-$7.7M+33.9%	-$11.6M	N/A	-$2.1M+76.6%	-$8.8M-312.2%	-$2.1M-295.3%	-$541K-108.3%	$6.5M	N/A	N/A	N/A
Investing Cash Flow	-$2.7M	-$2.0M-152.4%	-$798K+94.2%	-$13.8M-63910.6%	-$21K+97.4%	-$827K-602.2%	-$118K-120.0%	$589K+400.8%	-$196K-1252.1%	-$14K+90.0%	-$145K-229.3%	-$44K+99.3%	-$6.8M-37323.6%	$18K	$0	$0
Financing Cash Flow	$14.0M	$14.1M+178.5%	$5.0M-60.2%	$12.7M-63.8%	$35.0M+382.2%	$7.3M-41.7%	$12.5M+247.3%	$3.6M+80.4%	$2.0M-78.6%	$9.3M+238.6%	$2.7M+733.8%	$329K-34.7%	$504K+21188.6%	$2K+158.2%	$917	N/A
Dividends Paid	N/A	N/A	N/A	N/A	$5.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	$0-100.0%	$100K	N/A	$377K+88.4%	$200K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$1.7M-61.0%	-$1.1M+76.8%	-$4.6M-87.2%	-$2.5M-102.9%	-$1.2M-549.4%	-$186K+95.1%	-$3.8M-618.2%	$740K
Capital Expenditures	$64K+458.3%	$11K+44.4%	$8K-37.9%	$13K-43.6%	$23K+79.8%	$13K-82.7%	$72K-68.3%	$229K
Free Cash Flow	-$1.8M-65.2%	-$1.1M+76.6%	-$4.6M-86.6%	-$2.5M-100.2%	-$1.2M-519.8%	-$199K+94.9%	-$3.9M-864.4%	$511K
Investing Cash Flow	$115K+116.2%	-$709K+33.7%	-$1.1M-5.9%	-$1.0M-1506.3%	$72K+1116.0%	-$7K+99.3%	-$1.0M-2737.0%	-$35K
Financing Cash Flow	$1.8M+414.6%	$348K-92.6%	$4.7M-34.7%	$7.2M+348.3%	$1.6M+186.1%	$561K-65.4%	$1.6M-39.6%	$2.7M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A

Not reported in any period shown, so not listed: Dividends Paid.

COSM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

COSM quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	12.1%+4.2pp	7.9%-0.2pp	8.2%-3.7pp	11.8%-3.0pp	14.8%+0.3pp	14.5%+5.3pp	9.2%+2.7pp	6.5%0.0pp	6.5%-2.4pp	8.9%-0.3pp	9.2%-90.8pp	100.0%	N/A	N/A	N/A
Operating Margin	-25.6%+3.0pp	-28.6%+12.3pp	-40.9%-26.1pp	-14.8%-6.8pp	-8.1%-13.0pp	4.9%+5.5pp	-0.6%+2.7pp	-3.3%+12.9pp	-16.2%-13.2pp	-3.0%+79.9pp	-82.9%-176.0pp	93.2%+61.2pp	32.0%	N/A	N/A
Net Margin	-29.3%+0.4pp	-29.7%+5.0pp	-34.7%-7.3pp	-27.5%-13.3pp	-14.2%-15.6pp	1.5%+9.8pp	-8.3%+16.1pp	-24.4%-3.7pp	-20.7%-11.8pp	-8.9%	N/A	79.1%+51.8pp	27.3%	N/A	N/A
Return on Equity	-103.9%-37.9pp	-66.0%-14.5pp	-51.4%-16.2pp	-35.2%+146.6pp	-181.8%	N/A	N/A	N/A	N/A	N/A	N/A	110.4%	N/A	N/A	N/A
Return on Assets	-29.2%+0.6pp	-29.8%-1.7pp	-28.1%-7.8pp	-20.3%-4.2pp	-16.1%-18.0pp	1.9%+15.7pp	-13.8%+30.0pp	-43.8%+14.4pp	-58.2%-38.9pp	-19.3%	N/A	83.5%+55.1pp	28.4%	N/A	N/A
Current Ratio	1.000.0x	0.99-0.5x	1.51-1.1x	2.59+1.3x	1.33+0.1x	1.19+0.4x	0.75-0.1x	0.82+0.1x	0.69+0.2x	0.54+0.3x	0.29-3.8x	4.10	N/A	N/A	N/A
Debt-to-Equity	0.200.0x	0.17+0.1x	0.04-0.1x	0.130.0x	0.11	N/A	N/A	N/A	N/A	N/A	N/A	0.32	N/A	N/A	N/A
FCF Margin	-13.0%+1.9pp	-14.9%+16.8pp	-31.8%-2.1pp	-29.7%-16.0pp	-13.7%+7.3pp	-21.0%	N/A	-5.5%+23.8pp	-29.4%+2.3pp	-31.7%	-101.4%	85.1%	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	8.0%+0.3pp	7.7%-2.8pp	10.5%-4.7pp	15.2%+7.3pp	7.9%-7.1pp	14.9%+7.9pp	7.1%-2.7pp	9.7%
Operating Margin	-15.4%-3.2pp	-12.2%+45.7pp	-57.9%-47.3pp	-10.6%+7.3pp	-17.9%-11.9pp	-6.1%+57.0pp	-63.0%-45.0pp	-18.1%
Net Margin	-32.1%-16.4pp	-15.7%+35.8pp	-51.5%-20.2pp	-31.3%-12.1pp	-19.2%-13.2pp	-6.0%+17.6pp	-23.5%+44.0pp	-67.5%
Return on Equity	-29.4%-15.3pp	-14.1%+40.9pp	-55.1%-31.9pp	-23.1%-12.4pp	-10.8%-7.6pp	-3.1%+10.5pp	-13.6%+10.3pp	-23.9%
Return on Assets	-9.9%-5.4pp	-4.5%+11.0pp	-15.5%-7.8pp	-7.7%-3.1pp	-4.6%-3.1pp	-1.4%+4.7pp	-6.2%+6.8pp	-13.0%
Current Ratio	1.050.0x	1.08+0.1x	1.000.0x	0.990.0x	0.98-0.1x	1.05+0.1x	0.99-0.4x	1.44
Debt-to-Equity	0.150.0x	0.170.0x	0.200.0x	0.230.0x	0.200.0x	0.190.0x	0.170.0x	0.12
FCF Margin	-9.4%-3.4pp	-6.0%+17.3pp	-23.4%-8.9pp	-14.4%-6.1pp	-8.4%-6.9pp	-1.5%+26.0pp	-27.5%-31.6pp	4.1%

Similar Companies

Synergy Chc Corp SNYR

$1.6M

Zynex Inc ZYXI

$3.8M

111 YI

$30.4M

Edap Tms EDAP

$161.9M

Quipt Home Medical Corp QIPT

$162.3M

Where Cosmos Health Inc. Ranks

Frequently Asked Questions

What is Cosmos Health Inc.'s annual revenue?

Cosmos Health Inc. (COSM) reported $65.3M in total revenue for fiscal year 2025. This represents a 19.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cosmos Health Inc.'s revenue growing?

Cosmos Health Inc. (COSM) revenue grew by 19.9% year-over-year, from $54.4M to $65.3M in fiscal year 2025.

Is Cosmos Health Inc. profitable?

No, Cosmos Health Inc. (COSM) reported a net income of -$19.1M in fiscal year 2025, with a net profit margin of -29.3%.

What is Cosmos Health Inc.'s EBITDA?

Cosmos Health Inc. (COSM) had EBITDA of -$15.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cosmos Health Inc. have?

As of fiscal year 2025, Cosmos Health Inc. (COSM) had $716K in cash and equivalents against $3.8M in long-term debt.

What is Cosmos Health Inc.'s gross margin?

Cosmos Health Inc. (COSM) had a gross margin of 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cosmos Health Inc.'s operating margin?

Cosmos Health Inc. (COSM) had an operating margin of -25.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cosmos Health Inc.'s net profit margin?

Cosmos Health Inc. (COSM) had a net profit margin of -29.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cosmos Health Inc.'s return on equity (ROE)?

Cosmos Health Inc. (COSM) has a return on equity of -103.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cosmos Health Inc.'s free cash flow?

Cosmos Health Inc. (COSM) recorded an outflow of $8.5M in free cash flow during fiscal year 2025. This represents a -4.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cosmos Health Inc.'s operating cash flow?

Cosmos Health Inc. (COSM) recorded an outflow of $8.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Cosmos Health Inc.'s total assets?

Cosmos Health Inc. (COSM) had $65.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cosmos Health Inc.'s capital expenditures?

Cosmos Health Inc. (COSM) invested $56K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Cosmos Health Inc. spend on research and development?

Cosmos Health Inc. (COSM) invested $519K in research and development during fiscal year 2025.

How many shares does Cosmos Health Inc. have outstanding?

Cosmos Health Inc. (COSM) had 51M shares outstanding as of fiscal year 2025.

What is Cosmos Health Inc.'s current ratio?

Cosmos Health Inc. (COSM) had a current ratio of 1.00 as of fiscal year 2025, which is considered adequate.

What is Cosmos Health Inc.'s debt-to-equity ratio?

Cosmos Health Inc. (COSM) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cosmos Health Inc.'s return on assets (ROA)?

Cosmos Health Inc. (COSM) had a return on assets of -29.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Cosmos Health Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Cosmos Health Inc. (COSM) held $762K in cash, cash equivalents and investments, and reported an operating cash outflow of $8.4M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Cosmos Health Inc.'s Altman Z-Score?

Cosmos Health Inc. (COSM) has an Altman Z-Score of -2.40, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cosmos Health Inc.'s Piotroski F-Score?

Cosmos Health Inc. (COSM) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cosmos Health Inc.'s earnings high quality?

Cosmos Health Inc. (COSM) reported a net loss of $19.1M while operations used $8.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cosmos Health Inc. cover its interest payments?

Cosmos Health Inc. (COSM) reported an operating loss of $16.7M against $1.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cosmos Health Inc.?

Cosmos Health Inc. (COSM) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.